| 7 May 2019 | Availability of cancer decision-support tools: A cross-sectional survey of UK primary care | Price, SJ; Spencer, A; Medina-Lara, A; et al. |
| 4 April 2019 | Resumption of Attention Deficit Hyperactivity Disorder medication in early adulthood: findings from a UK primary care prescribing study | Newlove-Delgado, TV; Ford, T; Hamilton, W; et al. |
| 20 August 2019 | Direct access CT for suspicion of brain tumour: An analysis of referral pathways in a population-based patient group | Zienius, K; Chak-Lam, I; Park, J; et al. |
| 30 August 2019 | The usefulness of symptoms alone or combined for general practitioners in considering the diagnosis of a brain tumour: A case-control study using the clinical practice research database (CPRD) (2000-2014) | Ozawa, M; Brennan, PM; Zienius, K; et al. |
| 14 October 2019 | Blood markers for cancer | Watson, J; Mounce, L; Bailey, SER; et al. |
| 14 June 2019 | Evaluating diagnostic strategies for early detection of cancer: the CanTest Framework | Walter, F; Thompson, MJ; Wellwood, I; et al. |
| 7 February 2019 | Prescribing for young people with Attention Deficit Hyperactivity Disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink | Newlove-Delgado, TV; Hamilton, W; Ford, T; et al. |
| 18 June 2019 | Use of multiple inflammatory marker tests in primary care: Using Clinical Practice Research Datalink to evaluate accuracy | Watson, J; Jones, HE; Banks, J; et al. |
| 18 June 2019 | Added value and cascade effects of inflammatory marker tests in UK primary care: A cohort study from the Clinical Practice Research Datalink | Watson, J; Salisbury, C; Whiting, P; et al. |
| 15 January 2019 | Clinical implications of increased testing in primary care | Watson, J; Hamilton, F; Bailey, S; et al. |
